Invention Grant
- Patent Title: Antitumor antagonists
-
Application No.: US16457399Application Date: 2019-06-28
-
Publication No.: US11001635B2Publication Date: 2021-05-11
- Inventor: Jackie Sheng , Bo Liu , Margaret Karow
- Applicant: GENSUN BIOPHARMA, INC.
- Applicant Address: US CA Newbury Park
- Assignee: GENSUN BIOPHARMA, INC.
- Current Assignee: GENSUN BIOPHARMA, INC.
- Current Assignee Address: US CA Newbury Park
- Agency: Morris, Manning & Martin, LLP
- Agent Michael X. Ye
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; C07K16/22 ; C07K14/00 ; C07K14/71 ; C07K16/46 ; A61K39/00
Abstract:
Antitumor antagonists that bind specifically to immune checkpoint regulators, angiogenesis pathway regulators and/or TGF pathway regulators are disclosed. Also disclosed are methods for treating proliferative disorders, infections, and immunological disorders with the antitumor antagonists described herein.
Public/Granted literature
- US20200002426A1 ANTITUMOR ANTAGONISTS Public/Granted day:2020-01-02
Information query
